The management of diabetes in IndigenousAustralians in the primary care setting Oct 25, 2007
Indigenous Australians with diabetes had high rates of micro- and macrovascular disease ... When compared to non-Indigenous patients, Indigenous patients were more likely to have established macrovascular disease (adjusted Odds ratio 2 ... This cross-sectional study confirms Aboriginal ethnicity as a powerful risk factor for microvascular and macrovascular disease, which practitioners should use to identify candidates for intensive multifactorial intervention. (BioMed Central)
Noninvasive Test Assesses Diabetes Vascular Damage Dec 8, 2006
AGE has a deleterious effect on the walls of small and large blood vessels, leading to diabetes-related micro- and macrovascular disease. Therefore, skin autofluorescence can be a "tool that is able to give a rapid impression of the risk for diabetes complications," the authors explain in the current issue of Diabetes Care. (MEDLINEplus)
Anemia Often Develops in Type 2 Diabetics Nov 25, 2006
Thursday, November 23, 2006. NEW YORK (Reuters Health) - In patients with type 2 diabetes, a decrease in hemoglobin (Hb) is insidious and occurs predominantly in older people with chronic kidney disease and damaged large blood vessels, research suggests. (MEDLINEplus)
ACTOS (pioglitazone HCl) demonstrates significant improvements in cardiovascular outcomes Sep 15, 2006
It was a randomized, double-blind, placebo-controlled outcome study of 5,238 patients with type 2 diabetes and macrovascular disease. Patients were randomized to receive either ACTOS or placebo in addition to standard-of-care treatment (including the routine use of anti-hypertensives such as ACE inhibitors and beta blockers; glucose-lowering agents such as metformin, sulfonylureas and insulin; antiplatelet drugs such as aspirin, and lipid-modifying medicines such as statins and fibrates). (EurekAlert!)
Prognostic value of physicians assessment of compliance regarding all-cause mortality in patients with type 2 diabetes: primary care follow-up study Jul 7, 2006
Among other factors such as patient type (patients presenting at office, nursing home or visited patients), gender, age and a history of macrovascular disease, the physicians assessment of patient compliance was an important predictor of all-cause mortality. Patients whose compliance was assessed by the physician as very bad (6%) were significantly more likely to die during follow-up (OR = 2. (BioMed Central)
